IDSA announces first antibiotic stewardship excellence designations
The Infectious Diseases Society of America (IDSA) today announced the first two recipients to receive its Antimicrobial Stewardship Centers of Excellence (COE) designation: Saint John's Health Center in Santa Monica, Calif., and Summa Health, based in Akron, Ohio.
IDSA unveiled the Antimicrobial Stewardship COE program this month to recognize institutions that meet standards established by the Centers for Disease Control and Prevention for antimicrobial stewardship programs that are led by infectious disease physicians and ID-trained pharmacists.
IDSA President Paul Auwaerter, MD, MBA, said in the statement that IDSA is committed to stewardship programs as a key component in the battle against antimicrobial resistance, which leads to 23,000 deaths each year and costing $20 billion in unnecessary healthcare costs. He added that the COE program is a way to recognize groups that take the lead in establishing highly effective antimicrobial stewardship programs that help clinicians provide optimal anti-infective therapies.
The criteria for the IDSA's Antimicrobial Stewardship COE were developed by a workgroup and builds on guidelines in the CDC's Core Elements of Hospital Antibiotic Stewardship Programs. The IDSA says the COE program emphasizes a facility's ability to implement stewardship protocols using the electronic health record system and providing ongoing education to staff.
Health systems can learn more about and apply for the COE designation on the IDSA's web site. The application deadline is Dec 15, 2017.
Nov 2 IDSA statement
IDSA Antimicrobial Stewardship Center of Excellence information
Rate of longer-term IV antibiotics for UTIs in kids drops dramatically
A study involving hospitalized US children published today in Pediatrics determined that the proportion of infants who receive longer-term intravenous (IV) antibiotic treatment for urinary tract infections (UTIs) decreased markedly from 2005 to 2015 without an increase in hospital readmissions.
US researchers analyzed data from the Pediatric Health Information System database, looking for readmission within 30 days for a UTI. They found that the proportion of infants 60 days old and younger at 46 US children's hospitals who received IV antibiotics for 4 or more days for UTIs decreased from 50% in 2005 to 19% in 2015. They also found that the drop did not correlate with an increased rate of readmission to the hospital.
The authors conclude, "These findings support the safety of short-course IV antibiotic therapy for appropriately selected neonates."
Nov 2 Pediatrics abstract